Opportunity
SAM #508-26-3-2049-0029
Sole Source PET Radiopharmaceuticals Contract for Atlanta VA Medical Center
Buyer
VANCO 7
Posted
June 10, 2026
Respond By
June 15, 2026
Identifier
508-26-3-2049-0029
NAICS
325412, 424210
This notice announces the Atlanta VA Healthcare System's intent to award a sole source contract for PET radiopharmaceuticals. - Agency: Department of Veterans Affairs, Network Contracting Office 7 - Location: Atlanta VA Medical Center, Decatur, GA - Sole source vendor: PETNET Solutions - Products required: - Amyvid (F-18 florbetapir) - Tauvid (F-18 flortaucipir) - Cerianna (F-18 fluoroestradiol) - Posluma (F-18 flotufolastat) - Axumin (F-18 fluciclovine) - OEMs: - Eli Lilly (Amyvid, Tauvid, Cerianna) - Lantheus (Posluma) - Blue Earth Diagnostics (Axumin) - Services required: - Daily delivery of radiopharmaceuticals - Vendor must provide all labor, supervision, and transportation - Contract structure: - One-year base period - Four one-year option periods - Commercial opportunity is limited due to sole source justification, but similar manufacturers may be considered for future requirements.
Description
To supply Nuclear Medicine (NM) in the Atlanta Veterans Affairs Healthcare System (ATL VA HCS) with five specific radiopharmaceuticals: Amyvid (F-18 florbetapir); Tauvid (F-18 flortaucipir); Cerianna (F18 fluoroestradiol); Posluma (F18-flotufolastat); Axumin (F-18 fluciclovine). The contract shall be structured as a one-year contract with four (4) optional years.
The vendor shall provide all labor, supervision, and transportation necessary to provide daily delivery of Amyvid (F-18 florbetapir); Tauvid (F-18 flortaucipir); Cerianna (F18 fluoroestradiol); Posluma (F18-flotufolastat); Axumin (F-18 fluciclovine) to NM, located in the Atlanta Veterans Affairs Medical Center (ATL VAMC), 1670 Clairmont Road, Decatur, GA 30033.